Sharing clinical trial data : maximizing benefits, minimizing risk
著者
書誌事項
Sharing clinical trial data : maximizing benefits, minimizing risk
National Academies Press, c2015
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references
内容説明・目次
内容説明
Data sharing can accelerate new discoveries by avoiding duplicative trials, stimulating new ideas for research, and enabling the maximal scientific knowledge and benefits to be gained from the efforts of clinical trial participants and investigators. At the same time, sharing clinical trial data presents risks, burdens, and challenges. These include the need to protect the privacy and honor the consent of clinical trial participants; safeguard the legitimate economic interests of sponsors; and guard against invalid secondary analyses, which could undermine trust in clinical trials or otherwise harm public health.
Sharing Clinical Trial Data presents activities and strategies for the responsible sharing of clinical trial data. With the goal of increasing scientific knowledge to lead to better therapies for patients, this book identifies guiding principles and makes recommendations to maximize the benefits and minimize risks. This report offers guidance on the types of clinical trial data available at different points in the process, the points in the process at which each type of data should be shared, methods for sharing data, what groups should have access to data, and future knowledge and infrastructure needs.
Responsible sharing of clinical trial data will allow other investigators to replicate published findings and carry out additional analyses, strengthen the evidence base for regulatory and clinical decisions, and increase the scientific knowledge gained from investments by the funders of clinical trials. The recommendations of Sharing Clinical Trial Data will be useful both now and well into the future as improved sharing of data leads to a stronger evidence base for treatment. This book will be of interest to stakeholders across the spectrum of research-from funders, to researchers, to journals, to physicians, and ultimately, to patients.
Table of Contents
Front Matter
Summary
1 Introduction
2 Guiding Principles for Sharing Clinical Trial Data
3 The Roles and Responsibilities of Stakeholders in the Sharing of
Clinical Trial Data
4 The Clinical Trial Life Cycle and When to Share Data
5 Access to Clinical Trial Data: Governance
6 The Future of Data Sharing in a Changing Landscape
Appendix A: Study Approach
Appendix B: Concepts and Methods for De-identifying Clinical Trial
Data
Appendix C: Legal Discussion of Risks to Industry Sponsors
Appendix D: Clinical Trial Data Sharing Policies: Top 1-12
Pharmaceutical Companies Ranked by 2013 Market Capitalization
Appendix E: Biosketches of Committee Members
目次
- 1 Front Matter
- 2 Summary
- 3 1 Introduction
- 4 2 Guiding Principles for Sharing Clinical Trial Data
- 5 3 The Roles and Responsibilities of Stakeholders in the Sharing of Clinical Trial Data
- 6 4 The Clinical Trial Life Cycle and When to Share Data
- 7 5 Access to Clinical Trial Data: Governance
- 8 6 The Future of Data Sharing in a Changing Landscape
- 9 Appendix A: Study Approach
- 10 Appendix B: Concepts and Methods for De-identifying Clinical Trial Data
- 11 Appendix C: Legal Discussion of Risks to Industry Sponsors
- 12 Appendix D: Clinical Trial Data Sharing Policies: Top 1-12 Pharmaceutical Companies Ranked by 2013 Market Capitalization
- 13 Appendix E: Biosketches of Committee Members
「Nielsen BookData」 より
